Clinical Trial Update: Macrophage Stimulating Factor in the Treatment of Diabetic Wounds [NA]

View source ↗

Summary

A clinical trial (NCT06608303) evaluating macrophage stimulating factor for the treatment of diabetic wounds has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Foot Ulcer

Drugs mentioned

• Macrophage Stimulating Factor (macrophage colony-stimulating factor (CSF1))

Snippet

Sponsor: Peking University Third Hospital | Conditions: Diabetic Wound | NA | Status: COMPLETED